Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients

被引:10
作者
Blokx, WAM
Smit, JV
de Jong, EMGJ
Link, MMGM
van de Kerkhof, PCM
Ruiter, DJ
机构
[1] Univ Med Ctr St Radboud, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Med Ctr St Radboud, Dept Dermatol, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1001/archderm.138.1.61
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To compare the expression of keratin (K) 13 and K19 in cutaneous warts of renal transplant recipients (RTRs) and immunocompetent individuals (ICIs). Design: Retrospective, nonrandomized immunohistochemical study. Patients and Methods: Specimens from cutaneous warts of RTRs and ICIs were retrieved from the archives of the Department of Pathology, University Medical Center St Radboud, Nijmegen, the Netherlands. Twenty-one warts from RTRs and 21 from ICIs were examined. Nine RTRs (10 specimens) received either systemic acitretin or topical all-traps retinoic acid, and their effect on both keratins was assessed. Main Outcome Measures: Frequency and expression patterns of K13 and K19 in warts of RTRs vs ICIs and the effect of retinoids. Results: A significantly higher percentage of warts of RTRs expressed K13 compared with warts of ICIs (86% vs 14%, 18 vs 3 cases, respectively; P<.001). In warts of RTRs, retinoid treatment correlated significantly with a particularly strong, segmental K13 expression pattern, which we termed zebroid. Without use of retinoids, K13 was mostly restricted to suprabasal single cells. Keratin 19 was absent in all warts of both patient groups. Conclusions: Retinoids strongly correlate with K13 in a characteristic zebroid pattern in warts of RTRs, making K13 a sensitive marker for retinoid bioactivity in skin (lesions) of RTRs. In non-retinoid-treated RTRs, K13 is also frequently found in warts but without the dramatic zebroid pattern noted in retinoid-treated warts.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 29 条
[1]   RETINOID-DEPENDENT TRANSCRIPTIONAL SUPPRESSION OF CYTOKERATIN GENE-EXPRESSION IN HUMAN EPIDERMAL SQUAMOUS-CELL CARCINOMA-CELLS [J].
AGARWAL, C ;
RORKE, EA ;
BOYCE, M ;
HOWARD, J ;
CRISH, J ;
HUFEISEN, S ;
ECKERT, RL .
DIFFERENTIATION, 1993, 52 (02) :185-191
[2]  
BARR BBB, 1989, LANCET, V1, P124
[3]   PREVENTION OF SKIN-CANCER AND REDUCTION OF KERATOTIC SKIN-LESIONS DURING ACITRETIN THERAPY IN RENAL-TRANSPLANT RECIPIENTS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
BAVINCK, JNB ;
TIEBEN, LM ;
VANDERWOUDE, FJ ;
TEGZESS, AM ;
HERMANS, J ;
TERSCHEGGET, J ;
VERMEER, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1933-1938
[4]  
BOYLE J, 1984, LANCET, V1, P702
[5]   EFFECTS OF TOPICAL RETINOIDS ON CYTOSKELETAL PROTEINS - IMPLICATIONS FOR RETINOID EFFECTS ON EPIDERMAL DIFFERENTIATION [J].
EICHNER, R ;
KAHN, M ;
CAPETOLA, RJ ;
GENDIMENICO, GJ ;
MEZICK, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (02) :154-161
[6]  
ELIAS P M, 1987, Dermatologica (Basel), V175, P28
[7]   COMPARISON OF CD271 (ADAPALENE) AND ALL-TRANS-RETINOIC ACID IN HUMAN SKIN - DISSOCIATION OF EPIDERMAL EFFECTS AND CRABP-II MESSENGER-RNA EXPRESSION [J].
GRIFFITHS, CEM ;
ELDER, JT ;
BERNARD, BA ;
ROSSIO, P ;
CROMIE, MA ;
FINKEL, LJ ;
SHROOT, B ;
VOORHEES, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (03) :325-328
[8]   SIDE-EFFECT PROFILE OF ACITRETIN THERAPY IN PSORIASIS [J].
GUPTA, AK ;
GOLDFARB, MT ;
ELLIS, CN ;
VOORHEES, JJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (06) :1088-1093
[9]  
HEENAN PJ, 1996, INT HISTOLOGICAL CLA, V12
[10]   RETINOIDS AS IMPORTANT REGULATORS OF TERMINAL DIFFERENTIATION - EXAMINING KERATIN EXPRESSION IN INDIVIDUAL EPIDERMAL-CELLS AT VARIOUS STAGES OF KERATINIZATION [J].
KOPAN, R ;
TRASKA, G ;
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1987, 105 (01) :427-440